Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

...the issue is more related to the underlying business fundamentals with a R/S.. not necessarily a 'good product'.

'Researchers at the Stern School of Business at NYU and Emory University looked at more than 40 years of data, from 1962 to 2001, and found that of the 1,600 reverse splits, shares underperformed their non-split peers by 15.6% in the first year following the split, 36% in the second year and 54% in the third year.'

'Of course, while the shares may get an initial boost, don’t expect it to last. If a company’s fortunes—and shares—have been waning, savvy investors will see the reverse split as a big red flag and continue selling, sending the share price back down.

Most—although not all—reverse stock splits are seen in small penny stocks that have not been able to attain steady profitability and create value for their shareholders. I found that was the case in most of the biotechs’ recent reverse splits. Many are on the verge of bankruptcy, and they use a reverse split as a last-ditch effort to revive their failing fortunes.'

- https://cabotwealth.com/daily/how-to-invest/reverse-stock-splits-shareholders/

Sorry

I said I am in another RS stock with good product - going from 13 to 7 in first month and now over 160. RS are not the worst case if you have a good product